Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients
Open Access
- 9 December 2010
- journal article
- review article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 55 (1), 207-217
- https://doi.org/10.1016/j.jhep.2010.11.012
Abstract
No abstract availableThis publication has 72 references indexed in Scilit:
- Antiviral Treatment of Recurrent Hepatitis C After Liver Transplantation: Predictors of Response and Long-Term OutcomeTransplantation, 2009
- The Use of Cyclosporine for Recurrent Hepatitis C After Liver Transplant: A Randomized Pilot StudyDigestive Diseases and Sciences, 2009
- The natural history of recurrent hepatitis C and what influences thisLiver Transplantation, 2008
- Pegylated‐interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta‐analysis of prospective controlled studiesJournal of Viral Hepatitis, 2008
- Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver TransplantationAmerican Journal of Transplantation, 2008
- Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinomaJournal of Hepatology, 2007
- Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantationJournal of Hepatology, 2007
- Interferon-Based Combination Anti-Viral Therapy for Hepatitis C Virus After Liver Transplantation: A Review and Quantitative AnalysisAmerican Journal of Transplantation, 2006
- What determines the natural history of recurrent hepatitis C after liver transplantation?Journal of Hepatology, 2005
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002